We are live on ! Find out more
PRQR icon

ProQR Therapeutics
PRQR

50 hedge funds and large institutions have $125M invested in ProQR Therapeutics in 2019 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 16 increasing their positions, 12 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

33% more repeat investments, than reductions

Existing positions increased: 16 | Existing positions reduced: 12

5.06% less ownership

Funds ownership: 60.79% → 55.73% (-5.1%)

9% less funds holding

Funds holding: 55 → 50 (-5)

42% less capital invested

Capital invested by funds: $215M → $125M (-$90.2M)

45% less first-time investments, than exits

New positions opened: 6 | Existing positions closed: 11

50% less funds holding in top 10

Funds holding in top 10: 2 → 1 (-1)

Holders
50
Holders Change
-5
Holders Change %
-9.09%
% of All Funds
1.1%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
6
Increased
16
Reduced
12
Closed
11
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
SFM
Sphera Funds Management
Israel
+$3.55M
2
Wellington Management Group
Wellington Management Group
Massachusetts
+$3.4M
3
Renaissance Technologies
Renaissance Technologies
New York
+$675K
4
ACM
Aquilo Capital Management
California
+$661K
5
OAM
Oxford Asset Management
United Kingdom
+$512K

Top Sellers

Rank Fund Capital Flow
1
O
OrbiMed
New York
-$12.6M
2
HSBC Holdings
HSBC Holdings
United Kingdom
-$4.55M
3
ClearBridge Investments
ClearBridge Investments
New York
-$3.91M
4
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$3.13M
5
Jennison Associates
Jennison Associates
New York
-$1.84M
Name Holding Trade Value Shares
Change 		Change in
Stake
Fidelity International
26
Fidelity International
Bermuda
$232K +$321K +40,215 New
Northern Trust
27
Northern Trust
Illinois
$223K – – –
Deutsche Bank
28
Deutsche Bank
Germany
$217K +$162K +20,268 +114%
Allianz Asset Management
29
Allianz Asset Management
Germany
$181K -$59.9K -7,500 -19%
Geode Capital Management
30
Geode Capital Management
Massachusetts
$169K – – –
California State Teachers Retirement System (CalSTRS)
31
California State Teachers Retirement System (CalSTRS)
California
$153K – – –
VEA
32
Virtus ETF Advisers
New York
$132K -$10.2K -1,278 -5%
Two Sigma Investments
33
Two Sigma Investments
New York
$120K +$70.3K +8,807 +73%
MWNA
34
Marshall Wace North America
New York
$116K +$161K +20,193 New
CS
35
Credit Suisse
Switzerland
$106K +$17.9K +2,240 +14%
Vanguard Group
36
Vanguard Group
Pennsylvania
$79K – – –
Mitsubishi UFJ Asset Management
37
Mitsubishi UFJ Asset Management
Japan
$69K +$11.8K +1,483 +14%
GCP
38
GSA Capital Partners
United Kingdom
$65K +$89.7K +11,231 New
Wells Fargo
39
Wells Fargo
California
$63K – – –
ProShare Advisors
40
ProShare Advisors
Maryland
$61K -$6.45K -808 -7%
Group One Trading
41
Group One Trading
Illinois
$47K +$64.8K +8,120 New
Zurich Cantonal Bank
42
Zurich Cantonal Bank
Switzerland
$25K – – –
Morgan Stanley
43
Morgan Stanley
New York
$14K +$2.93K +367 +18%
Barclays
44
Barclays
United Kingdom
$12K +$1.63K +204 +10%
ClearBridge Investments
45
ClearBridge Investments
New York
$6K -$3.91M -489,798 -100%
Citigroup
46
Citigroup
New York
$6K +$958 +120 +13%
Royal Bank of Canada
47
Royal Bank of Canada
Ontario, Canada
$4K +$4.39K +550 +275%
LC
48
Lindbrook Capital
California
$3K +$2.4K +300 +100%
Daiwa Securities Group
49
Daiwa Securities Group
Japan
$1K – – –
O
50
OrbiMed
New York
– -$12.6M -1,382,502 Closed
1
2
3

PRQR Hedge Fund Activity: Q3 2019 in Review

50 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in ProQR Therapeutics (PRQR) for Q3 2019, worth a combined $125M — down 42% from $215M a quarter earlier.

Sellers outnumbered buyers: 11 funds closed out of PRQR and 6 opened new positions — a net loss of 5 holders — while 12 trimmed existing stakes and 16 added.

The largest buyer was Sphera Funds Management, adding an estimated $3.55M. The largest seller was OrbiMed, exiting entirely with an estimated $12.6M sold.

  • 50 institutional investors held ProQR Therapeutics (PRQR) as of Q3 2019, down from 55 in Q2 2019.
  • Funds reported $125M of ProQR Therapeutics stock for Q3 2019, down 42% quarter-over-quarter.
  • 6 funds opened new ProQR Therapeutics positions in Q3 2019 and 11 closed out, a net change of -5 holders.
  • The largest ProQR Therapeutics buyer in Q3 2019 was Sphera Funds Management, an estimated $3.55M added.
  • The largest ProQR Therapeutics seller in Q3 2019 was OrbiMed, an estimated $12.6M sold.

Based on aggregated 13F filings for Q3 2019.